EcoDrugPlus

Aurora Kinase B

Ensembl ID : ENSPPRG00000001075
Gene Symbol: AURKB
4 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSPPRG00000012921
Gene Symbol: AURKC
3 Cross references
96 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSPPRG00000025033
Gene Symbol: BACE1
4 Cross references
217 Possible Orthologues:

Bradykinin Receptor B1

Ensembl ID : ENSPPRG00000010354
Gene Symbol: BDKRB1
1 Cross references
147 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSPPRG00000010469
Gene Symbol: BDKRB2
4 Cross references
356 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSPPRG00000015130
Gene Symbol: BCHE
4 Cross references
130 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSPPRG00000024965
Gene Symbol: CALCRL
3 Cross references
147 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSPPRG00000014081
Gene Symbol: CASR
4 Cross references
202 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 1

Ensembl ID : ENSPPRG00000011796
Gene Symbol: CACNA2D1
4 Cross references
285 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 2

Ensembl ID : ENSPPRG00000022571
Gene Symbol: CACNA2D2
4 Cross references
272 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 3

Ensembl ID : ENSPPRG00000008211
Gene Symbol: CACNA2D3
4 Cross references
307 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 4

Ensembl ID : ENSPPRG00000007443
Gene Symbol: CACNA2D4
3 Cross references
317 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).